Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy
Xingmei Duan,1,2,* Minjie Mu,3,* Junfeng Yan,1 Lan Bai,1 Lei Zhong,1 Yuxuan Zhu,1 Haixia Pan,1 Mei Zhang,3 Jianyou Shi1,3 1Personalized Drug Therapy Key Laboratory of Sichuan Province, Department of Pharmacy, Sichuan Provincial People`s Hospital, Chengdu, 2State Key Laboratory of Biotherapy and Can...
Guardado en:
Autores principales: | Duan X, Mu M, Yan J, Bai L, Zhong L, Zhu Y, Pan H, Zhang M, Shi J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1dc923d6e765497b874a3252b5f1e751 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Ortografía y fonética en la Aurora de Chile
por: Almau Almau,Sonia
Publicado: (2010) -
Aurora Bertrana: bringing "otherness" home
por: Pilar Godayol
Publicado: (2010) -
Self-Assembled DNA Nanostructure as a Carrier for Targeted siRNA Delivery in Glioma Cells
por: Zhou Y, et al.
Publicado: (2021) -
Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts.
por: Fariba Némati, et al.
Publicado: (2014) -
Uveal melanoma: epidemiology, etiology, and treatment of primary disease
por: Krantz BA, et al.
Publicado: (2017)